Drug Development

Weight Loss Drugs Clinical Trials Market Trends Obesity Treatments Market Competition Research and Development Oncology Obesity Drugs Market Access Weight Loss Medications

52 ARTICLES

last mo.

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Priced from ₹17,345 to ₹26,050 per month, the weekly semaglutide injection targets $1 billion in sales over seven years, facing growing competition as its patent nears expiry.

9 ARTICLES

last mo.

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

7 ARTICLES

2mo ago

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

3 ARTICLES

2mo ago

Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707

31 ARTICLES

2mo ago

Novo Nordisk CEO Steps Down Following Share Price Collapse

4 ARTICLES

2mo ago

Novo Nordisk CEO Steps Down Following Market Challenges

5 ARTICLES

2mo ago

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

3 ARTICLES

2mo ago

Bayer Reports 35% Profit Decline as Agricultural Weakness Persists

14 ARTICLES

2mo ago

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

10 ARTICLES

3mo ago

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

6 ARTICLES

3mo ago

Bayer Proposes €8 Billion Capital Increase to Address Mounting Glyphosate Litigation

4 ARTICLES

3mo ago

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

12 ARTICLES

3mo ago

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

3 ARTICLES

3mo ago

Pfizer Halts Development of Danuglipron After Liver Safety Concerns

6 ARTICLES

4mo ago

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Particle.news

Drug Development

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration

Wockhardt Files for Zaynich Approval in India, Plans USFDA Submission

FDA launches AI assistant Elsa early as staff flag readiness issues

Indivior to Abandon London Listing to Focus Solely on Nasdaq

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707

Novo Nordisk CEO Steps Down Following Share Price Collapse

Never miss stories about

Drug Development

Novo Nordisk CEO Steps Down Following Market Challenges

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

Bayer Reports 35% Profit Decline as Agricultural Weakness Persists

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Bayer Proposes €8 Billion Capital Increase to Address Mounting Glyphosate Litigation

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Pfizer Halts Development of Danuglipron After Liver Safety Concerns

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Never miss stories about

Drug Development